JACC: CardioOncology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1212621, encodeId=ff42121262138, content=偏重的研究方向：肿瘤心脏学 经验分享：研究论文，20年4月底投稿，8月份修稿，8月底接收，11月见刊。非常nice的杂志，季刊，2019年底创刊，2020年拿到第一个****6.25，进入JCR Q1，中科院2区(大区)。未来继续看涨。肿瘤心脏病学(心内科新的亚专科)的顶刊，国内目前有3-4篇原研论文。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200629/d169d4937b324455a3249d892ed83877/d376345dc0e948b7a633e8d02236c5b2.jpg, createdBy=37541652813, createdName=杜医生, createdTime=Tue Apr 19 19:13:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2210810, encodeId=c6952210810df, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心肌损伤;肿瘤心脏病学;心脏肿瘤病学 经验分享：JACC: CardioOncology 12分，太厉害了，刚刚有，影响因子就能达到12分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 14:14:27 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2124569, encodeId=36092124569ed, content=偏重的研究方向：心脏肿瘤学 经验分享：请问大家这个杂志接收case report不允许有共同一作和共同通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7918235283, createdName=ms2000002026011553, createdTime=Sun Apr 09 12:03:25 CST 2023, time=2023-04-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=944091, encodeId=553a94409110, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤心脏学;免疫治疗;心脏损伤 经验分享：主要面向肿瘤心脏病学这个新学科，现在肿瘤免疫治疗、化疗等可能会带来心血管的副作用，因此，出现了这门新学科，这个期刊不能错过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sun Feb 28 10:11:54 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602372, encodeId=11b16023e2ed, content=审稿速度:2.0 | 审稿费用:1000.0 | 版面费用:500.0 偏重的研究方向：肿瘤 经验分享：非常的棒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/5924e86cc73c43efb5bad9dd92ac0d7b/63609a5527c447f48b59b39dd248a66f.jpg, createdBy=cf0a5102349, createdName=站在塔尖, createdTime=Tue Jun 16 20:20:26 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113182, encodeId=f80d1113182a4, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113181, encodeId=6f8a111318112, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2022-04-19 杜医生

偏重的研究方向：肿瘤心脏学
经验分享：研究论文，20年4月底投稿，8月份修稿，8月底接收，11月见刊。非常nice的杂志，季刊，2019年底创刊，2020年拿到第一个****6.25，进入JCR Q1，中科院2区(大区)。未来继续看涨。肿瘤心脏病学(心内科新的亚专科)的顶刊，国内目前有3-4篇原研论文。

178 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1212621, encodeId=ff42121262138, content=偏重的研究方向：肿瘤心脏学 经验分享：研究论文，20年4月底投稿，8月份修稿，8月底接收，11月见刊。非常nice的杂志，季刊，2019年底创刊，2020年拿到第一个****6.25，进入JCR Q1，中科院2区(大区)。未来继续看涨。肿瘤心脏病学(心内科新的亚专科)的顶刊，国内目前有3-4篇原研论文。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200629/d169d4937b324455a3249d892ed83877/d376345dc0e948b7a633e8d02236c5b2.jpg, createdBy=37541652813, createdName=杜医生, createdTime=Tue Apr 19 19:13:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2210810, encodeId=c6952210810df, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心肌损伤;肿瘤心脏病学;心脏肿瘤病学 经验分享：JACC: CardioOncology 12分，太厉害了，刚刚有，影响因子就能达到12分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 14:14:27 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2124569, encodeId=36092124569ed, content=偏重的研究方向：心脏肿瘤学 经验分享：请问大家这个杂志接收case report不允许有共同一作和共同通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7918235283, createdName=ms2000002026011553, createdTime=Sun Apr 09 12:03:25 CST 2023, time=2023-04-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=944091, encodeId=553a94409110, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤心脏学;免疫治疗;心脏损伤 经验分享：主要面向肿瘤心脏病学这个新学科，现在肿瘤免疫治疗、化疗等可能会带来心血管的副作用，因此，出现了这门新学科，这个期刊不能错过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sun Feb 28 10:11:54 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602372, encodeId=11b16023e2ed, content=审稿速度:2.0 | 审稿费用:1000.0 | 版面费用:500.0 偏重的研究方向：肿瘤 经验分享：非常的棒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/5924e86cc73c43efb5bad9dd92ac0d7b/63609a5527c447f48b59b39dd248a66f.jpg, createdBy=cf0a5102349, createdName=站在塔尖, createdTime=Tue Jun 16 20:20:26 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113182, encodeId=f80d1113182a4, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113181, encodeId=6f8a111318112, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2024-06-20 侠胆医心来自伊利诺伊

审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向：心肌损伤;肿瘤心脏病学;心脏肿瘤病学
经验分享：JACC: CardioOncology 12分，太厉害了，刚刚有，影响因子就能达到12分

76 0

[GetPortalCommentsPageByObjectIdResponse(id=1212621, encodeId=ff42121262138, content=偏重的研究方向：肿瘤心脏学 经验分享：研究论文，20年4月底投稿，8月份修稿，8月底接收，11月见刊。非常nice的杂志，季刊，2019年底创刊，2020年拿到第一个****6.25，进入JCR Q1，中科院2区(大区)。未来继续看涨。肿瘤心脏病学(心内科新的亚专科)的顶刊，国内目前有3-4篇原研论文。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200629/d169d4937b324455a3249d892ed83877/d376345dc0e948b7a633e8d02236c5b2.jpg, createdBy=37541652813, createdName=杜医生, createdTime=Tue Apr 19 19:13:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2210810, encodeId=c6952210810df, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心肌损伤;肿瘤心脏病学;心脏肿瘤病学 经验分享：JACC: CardioOncology 12分，太厉害了，刚刚有，影响因子就能达到12分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 14:14:27 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2124569, encodeId=36092124569ed, content=偏重的研究方向：心脏肿瘤学 经验分享：请问大家这个杂志接收case report不允许有共同一作和共同通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7918235283, createdName=ms2000002026011553, createdTime=Sun Apr 09 12:03:25 CST 2023, time=2023-04-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=944091, encodeId=553a94409110, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤心脏学;免疫治疗;心脏损伤 经验分享：主要面向肿瘤心脏病学这个新学科，现在肿瘤免疫治疗、化疗等可能会带来心血管的副作用，因此，出现了这门新学科，这个期刊不能错过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sun Feb 28 10:11:54 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602372, encodeId=11b16023e2ed, content=审稿速度:2.0 | 审稿费用:1000.0 | 版面费用:500.0 偏重的研究方向：肿瘤 经验分享：非常的棒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/5924e86cc73c43efb5bad9dd92ac0d7b/63609a5527c447f48b59b39dd248a66f.jpg, createdBy=cf0a5102349, createdName=站在塔尖, createdTime=Tue Jun 16 20:20:26 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113182, encodeId=f80d1113182a4, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113181, encodeId=6f8a111318112, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2023-04-09 ms2000002026011553 来自辽宁省

偏重的研究方向：心脏肿瘤学
经验分享：请问大家这个杂志接收case report不允许有共同一作和共同通讯吗

158 0

[GetPortalCommentsPageByObjectIdResponse(id=1212621, encodeId=ff42121262138, content=偏重的研究方向：肿瘤心脏学 经验分享：研究论文，20年4月底投稿，8月份修稿，8月底接收，11月见刊。非常nice的杂志，季刊，2019年底创刊，2020年拿到第一个****6.25，进入JCR Q1，中科院2区(大区)。未来继续看涨。肿瘤心脏病学(心内科新的亚专科)的顶刊，国内目前有3-4篇原研论文。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200629/d169d4937b324455a3249d892ed83877/d376345dc0e948b7a633e8d02236c5b2.jpg, createdBy=37541652813, createdName=杜医生, createdTime=Tue Apr 19 19:13:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2210810, encodeId=c6952210810df, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心肌损伤;肿瘤心脏病学;心脏肿瘤病学 经验分享：JACC: CardioOncology 12分，太厉害了，刚刚有，影响因子就能达到12分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 14:14:27 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2124569, encodeId=36092124569ed, content=偏重的研究方向：心脏肿瘤学 经验分享：请问大家这个杂志接收case report不允许有共同一作和共同通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7918235283, createdName=ms2000002026011553, createdTime=Sun Apr 09 12:03:25 CST 2023, time=2023-04-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=944091, encodeId=553a94409110, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤心脏学;免疫治疗;心脏损伤 经验分享：主要面向肿瘤心脏病学这个新学科，现在肿瘤免疫治疗、化疗等可能会带来心血管的副作用，因此，出现了这门新学科，这个期刊不能错过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sun Feb 28 10:11:54 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602372, encodeId=11b16023e2ed, content=审稿速度:2.0 | 审稿费用:1000.0 | 版面费用:500.0 偏重的研究方向：肿瘤 经验分享：非常的棒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/5924e86cc73c43efb5bad9dd92ac0d7b/63609a5527c447f48b59b39dd248a66f.jpg, createdBy=cf0a5102349, createdName=站在塔尖, createdTime=Tue Jun 16 20:20:26 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113182, encodeId=f80d1113182a4, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113181, encodeId=6f8a111318112, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-02-28 小小医者

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤心脏学;免疫治疗;心脏损伤
经验分享：主要面向肿瘤心脏病学这个新学科，现在肿瘤免疫治疗、化疗等可能会带来心血管的副作用，因此，出现了这门新学科，这个期刊不能错过

229 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1212621, encodeId=ff42121262138, content=偏重的研究方向：肿瘤心脏学 经验分享：研究论文，20年4月底投稿，8月份修稿，8月底接收，11月见刊。非常nice的杂志，季刊，2019年底创刊，2020年拿到第一个****6.25，进入JCR Q1，中科院2区(大区)。未来继续看涨。肿瘤心脏病学(心内科新的亚专科)的顶刊，国内目前有3-4篇原研论文。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200629/d169d4937b324455a3249d892ed83877/d376345dc0e948b7a633e8d02236c5b2.jpg, createdBy=37541652813, createdName=杜医生, createdTime=Tue Apr 19 19:13:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2210810, encodeId=c6952210810df, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心肌损伤;肿瘤心脏病学;心脏肿瘤病学 经验分享：JACC: CardioOncology 12分，太厉害了，刚刚有，影响因子就能达到12分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 14:14:27 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2124569, encodeId=36092124569ed, content=偏重的研究方向：心脏肿瘤学 经验分享：请问大家这个杂志接收case report不允许有共同一作和共同通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7918235283, createdName=ms2000002026011553, createdTime=Sun Apr 09 12:03:25 CST 2023, time=2023-04-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=944091, encodeId=553a94409110, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤心脏学;免疫治疗;心脏损伤 经验分享：主要面向肿瘤心脏病学这个新学科，现在肿瘤免疫治疗、化疗等可能会带来心血管的副作用，因此，出现了这门新学科，这个期刊不能错过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sun Feb 28 10:11:54 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602372, encodeId=11b16023e2ed, content=审稿速度:2.0 | 审稿费用:1000.0 | 版面费用:500.0 偏重的研究方向：肿瘤 经验分享：非常的棒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/5924e86cc73c43efb5bad9dd92ac0d7b/63609a5527c447f48b59b39dd248a66f.jpg, createdBy=cf0a5102349, createdName=站在塔尖, createdTime=Tue Jun 16 20:20:26 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113182, encodeId=f80d1113182a4, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113181, encodeId=6f8a111318112, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2020-06-16 站在塔尖

审稿速度:2.0 | 审稿费用:1000.0 | 版面费用:500.0
偏重的研究方向：肿瘤
经验分享：非常的棒

218 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1212621, encodeId=ff42121262138, content=偏重的研究方向：肿瘤心脏学 经验分享：研究论文，20年4月底投稿，8月份修稿，8月底接收，11月见刊。非常nice的杂志，季刊，2019年底创刊，2020年拿到第一个****6.25，进入JCR Q1，中科院2区(大区)。未来继续看涨。肿瘤心脏病学(心内科新的亚专科)的顶刊，国内目前有3-4篇原研论文。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200629/d169d4937b324455a3249d892ed83877/d376345dc0e948b7a633e8d02236c5b2.jpg, createdBy=37541652813, createdName=杜医生, createdTime=Tue Apr 19 19:13:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2210810, encodeId=c6952210810df, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心肌损伤;肿瘤心脏病学;心脏肿瘤病学 经验分享：JACC: CardioOncology 12分，太厉害了，刚刚有，影响因子就能达到12分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 14:14:27 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2124569, encodeId=36092124569ed, content=偏重的研究方向：心脏肿瘤学 经验分享：请问大家这个杂志接收case report不允许有共同一作和共同通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7918235283, createdName=ms2000002026011553, createdTime=Sun Apr 09 12:03:25 CST 2023, time=2023-04-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=944091, encodeId=553a94409110, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤心脏学;免疫治疗;心脏损伤 经验分享：主要面向肿瘤心脏病学这个新学科，现在肿瘤免疫治疗、化疗等可能会带来心血管的副作用，因此，出现了这门新学科，这个期刊不能错过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sun Feb 28 10:11:54 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602372, encodeId=11b16023e2ed, content=审稿速度:2.0 | 审稿费用:1000.0 | 版面费用:500.0 偏重的研究方向：肿瘤 经验分享：非常的棒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/5924e86cc73c43efb5bad9dd92ac0d7b/63609a5527c447f48b59b39dd248a66f.jpg, createdBy=cf0a5102349, createdName=站在塔尖, createdTime=Tue Jun 16 20:20:26 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113182, encodeId=f80d1113182a4, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113181, encodeId=6f8a111318112, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-12-29 Gym璨烨

摘要中一定要加入研究目标么？

178 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1212621, encodeId=ff42121262138, content=偏重的研究方向：肿瘤心脏学 经验分享：研究论文，20年4月底投稿，8月份修稿，8月底接收，11月见刊。非常nice的杂志，季刊，2019年底创刊，2020年拿到第一个****6.25，进入JCR Q1，中科院2区(大区)。未来继续看涨。肿瘤心脏病学(心内科新的亚专科)的顶刊，国内目前有3-4篇原研论文。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200629/d169d4937b324455a3249d892ed83877/d376345dc0e948b7a633e8d02236c5b2.jpg, createdBy=37541652813, createdName=杜医生, createdTime=Tue Apr 19 19:13:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2210810, encodeId=c6952210810df, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心肌损伤;肿瘤心脏病学;心脏肿瘤病学 经验分享：JACC: CardioOncology 12分，太厉害了，刚刚有，影响因子就能达到12分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 14:14:27 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2124569, encodeId=36092124569ed, content=偏重的研究方向：心脏肿瘤学 经验分享：请问大家这个杂志接收case report不允许有共同一作和共同通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7918235283, createdName=ms2000002026011553, createdTime=Sun Apr 09 12:03:25 CST 2023, time=2023-04-09, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=944091, encodeId=553a94409110, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤心脏学;免疫治疗;心脏损伤 经验分享：主要面向肿瘤心脏病学这个新学科，现在肿瘤免疫治疗、化疗等可能会带来心血管的副作用，因此，出现了这门新学科，这个期刊不能错过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sun Feb 28 10:11:54 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602372, encodeId=11b16023e2ed, content=审稿速度:2.0 | 审稿费用:1000.0 | 版面费用:500.0 偏重的研究方向：肿瘤 经验分享：非常的棒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/5924e86cc73c43efb5bad9dd92ac0d7b/63609a5527c447f48b59b39dd248a66f.jpg, createdBy=cf0a5102349, createdName=站在塔尖, createdTime=Tue Jun 16 20:20:26 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113182, encodeId=f80d1113182a4, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113181, encodeId=6f8a111318112, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-12-27 衣谷

摘要一定要描述使用的方法么？

182 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务